Versuchen GOLD - Frei

Current Nutraceuticals Regulatory Landscape— India And Key Export Markets

Express Pharma

|

November 01-15, 2019

An excerpt from 'Indian Nutraceuticals Industry - Building Global Momentum amid Regulatory Challenges', a report released by ASSOCHAM and Sathguru Management Consultants encompassing various national and global regulatory provisions dealing with the Nutraceuticals Landscape

Current Nutraceuticals Regulatory Landscape— India And Key Export Markets

The term nutraceuticalsis perceived to include different product types in different geographies across the world and the sheer lack of standardization in global definition of nutraceuticals is one of the key challenges faced by manufacturers wanting to export products. For example, nutraceutical derived supplement products are referred to as “dietary supplements” in the US, “Natural Health Product (NHP)” or “traditional herbal medicine” in the European Union and “complementary medicine” in Australia. The regulatory stipulations for nutraceuticals becomes more complex if in addition to being dietary supplements, they are also based on traditional systems of medicine such as TCM in China and Ayurvedic/Unani/ Siddha medicine in India.

Thus differentiation between the manner in which nations regulate the practice of medicine and the manner in which they regulate products used in medicine and food is important. In India, there is central regulation for the whole country when it comes to practice of medicine as well as the food and drugs, unlike in the US, where practice of medicine is regulated by the state authorities and the marketing of food and drugs is regulated by the central FDA.

Codex Alimentarius refer to a set of international guidelines followed by national regulatory bodies and manufactures of international quality food products. It has blanketed Food for special dietary needs to include food specifically processed and formulated for satisfying the dietary requirements of people with special physiological or physical issues. These also include food for special medical purpose which covers food formulations for people with specific diseases and disorders and the composition of such food formulation must be different from ordinary food products.

WEITERE GESCHICHTEN VON Express Pharma

Express Pharma

Express Pharma

Speed and flexibility play a critical role in how we compete with larger global players

Kriti Jajoo, VP-BD and Strategy, Shriji Polymers, as the next-gen leader, speaks on how the company is evolving with a leadership approach that balances technology, sustainability, and customer-centricity to create long-term value, in an interview with Express Pharma

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Vizag rising: Shaping India's pharma future

At the Vizag Pharma Summit 2025, hosted by Express Pharma, industry leaders discussed how quality, R&D, compliance, and emerging technologies are driving India's next phase of pharma growth

time to read

9 mins

January 2026

Express Pharma

Express Pharma

Future of pharma: Trends, challenges & AI

Industry experts discussed how Al is transforming pharmaceutical R&D, highlighting both the promise and the practical limitations of current technologies

time to read

2 mins

January 2026

Express Pharma

Express Pharma

Gandhi Automations presents multi-composites, high-performance door PRIME NEO for clean environments

When it comes to pharmaceutical facilities and laboratories, clean rooms' hygiene and protection from environmental contamination are the most important factors to consider.

time to read

1 mins

January 2026

Express Pharma

Express Pharma

Can Indian biosimilars and generics restate accessibility in global underserved markets?

Hari Kiran Chereddi, MD & CEO - HRV Pharma & NHG Pharma highlights that India's success in generics is no longer enough, as the world now demands advanced biologics, biosimilars, and personalised medicines. He further emphasises on the need for stronger regulation, innovation, and investment so India can lead in next-generation therapies and expand global access to cutting-edge healthcare

time to read

3 mins

January 2026

Express Pharma

Express Pharma

The next wave of growth will belong not to the fastest manufacturers but to the most innovative problem-solvers

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening formulation R&D, building a skilled and adaptable workforce, and closing gaps between academic research and industry needs.

time to read

6 mins

January 2026

Express Pharma

Express Pharma

Results win customers. Leadership discipline keeps them

Drawing themes from his new book The Dual Mandate in B2B - Driving Results. Shaping Culture, Mohan Joshi - Global C-Suite Partner & Former President, SCHOTT India, discusses leadership systems, alignment, and execution in conversation with Neha Aathavale.

time to read

3 mins

January 2026

Express Pharma

Express Pharma

INDIA'S INNOVATION JOURNEY FROM PROMISE TO PROOF

India's pharma ecosystem is ready to embrace stronger science and bolder ideas. Turning early breakthroughs into scalable, sustainable innovation remains the challenge

time to read

8 mins

January 2026

Express Pharma

Express Pharma

PRUV® -The original Sodium Stearyl Fumarate

JRS Pharma's PRUV® is the original sodium stearyl fumarate (SSF) introduced in the market over 20 years ago

time to read

5 mins

January 2026

Express Pharma

Express Pharma

Odisha's pharma pitch

The inaugural Odisha Pharma Summit 2025 delivered strong early signals of intent, positioning the state as an upcoming destination for PLI-triggered expansions, to complement existing pharma hubs. As Hemant Sharma, ACS Industry Dept and I&PR Dept, Govt of Odisha puts it, the aim is to “become a good, viable second option.” How fast can the eastern newcomer catch up and become India's next life sciences hub, asks Viveka Roychowdhury

time to read

5 mins

January 2026

Translate

Share

-
+

Change font size